Trials / Completed
CompletedNCT00946725
To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg
A Comparative Bioavailability Study of Atenolol Tablets, 100 mg
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of atenolol tablets, 100 mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atenolol (Tenormin) 100 mg Tablets Zeneca (Astra Zeneca Pharmaceutical) | |
| DRUG | Atenolol 100 mg Tablets (Geneva Pharmaceutical, Inc.) |
Timeline
- Start date
- 2000-11-01
- Primary completion
- 2000-11-01
- Completion
- 2000-11-01
- First posted
- 2009-07-27
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00946725. Inclusion in this directory is not an endorsement.